These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1452399)
21. Effect of sodium chloride concentration on fluid-phase assembly and stability of the C3 convertase of the classical pathway of the complement system. Maeda S; Nagasawa S Biochem J; 1990 Nov; 271(3):749-54. PubMed ID: 2244876 [TBL] [Abstract][Full Text] [Related]
22. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro. Weiler JM; Gleich GJ J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544 [TBL] [Abstract][Full Text] [Related]
23. Phytochemical Analysis and Anti-cancer Investigation of Boswellia serrata Bioactive Constituents In Vitro. Ahmed HH; Abd-Rabou AA; Hassan AZ; Kotob SE Asian Pac J Cancer Prev; 2015; 16(16):7179-88. PubMed ID: 26514509 [TBL] [Abstract][Full Text] [Related]
24. Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase. Burge J; Nicholson-Weller A; Austen KF J Immunol; 1981 Jan; 126(1):232-5. PubMed ID: 6778916 [TBL] [Abstract][Full Text] [Related]
25. Murine membrane inhibitor of complement which accelerates decay of human C3 convertase. Kameyoshi Y; Matsushita M; Okada H Immunology; 1989 Dec; 68(4):439-44. PubMed ID: 2481641 [TBL] [Abstract][Full Text] [Related]
26. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement. Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304 [TBL] [Abstract][Full Text] [Related]
27. The purification and properties of the second component of guinea-pig complement. Kerr MA; Gagnon J Biochem J; 1982 Jul; 205(1):59-67. PubMed ID: 6922702 [TBL] [Abstract][Full Text] [Related]
28. Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme. Halbwachs L; Leveillé M; Lesavre P; Wattel S; Leibowitch J J Clin Invest; 1980 Jun; 65(6):1249-56. PubMed ID: 6902727 [TBL] [Abstract][Full Text] [Related]
29. The human complement system: assembly of the classical pathway C3 convertase. Kerr MA Biochem J; 1980 Jul; 189(1):173-81. PubMed ID: 6906228 [TBL] [Abstract][Full Text] [Related]
30. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system. Kitamura H; Tsuboi M; Nagaki K Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b. Sahu A; Rawal N; Pangburn MK Biochem Pharmacol; 1999 Jun; 57(12):1439-46. PubMed ID: 10353266 [TBL] [Abstract][Full Text] [Related]
32. Boswellia serrata oleo-gum-resin and β-boswellic acid inhibits HSV-1 infection in vitro through modulation of NF-кB and p38 MAP kinase signaling. Goswami D; Mahapatra AD; Banerjee S; Kar A; Ojha D; Mukherjee PK; Chattopadhyay D Phytomedicine; 2018 Dec; 51():94-103. PubMed ID: 30466633 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of cleavage of the third component of human complement (C3) by its small cleavage fragment, C3a: inhibition occurs with the classical-pathway, but not the alternative-pathway, C3 convertase. Strunk RC; Webster RO Mol Immunol; 1985 Jan; 22(1):37-43. PubMed ID: 3871899 [TBL] [Abstract][Full Text] [Related]
34. Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b. Maillet F; Kazatchkine MD; Glotz D; Fischer E; Rowe M Mol Immunol; 1983 Dec; 20(12):1401-4. PubMed ID: 6558419 [TBL] [Abstract][Full Text] [Related]
35. Generation of the classical pathway C3 convertase (EAC4b2a) by proteolytic enzymes. Loos M; Heinz HP Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():67-74. PubMed ID: 6375257 [TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of the C3 convertase of the classical pathway of human complement system by size exclusion high-performance liquid chromatography. Nagasawa S; Kobayashi C; Maki-Suzuki T; Yamashita N; Koyama J J Biochem; 1985 Feb; 97(2):493-9. PubMed ID: 3874204 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of boswellic acid-NSAID hybrid molecules as anti-inflammatory and anti-arthritic agents. Shenvi S; Kiran KR; Kumar K; Diwakar L; Reddy GC Eur J Med Chem; 2015 Jun; 98():170-8. PubMed ID: 26010018 [TBL] [Abstract][Full Text] [Related]
38. Factor J, an inhibitor of the classical and alternative complement pathway, does not inhibit esterolysis by factor D. González-Rubio C; González-Muñiz R; Jiménez-Clavero MA; Fontán G; López-Trascasa M Biochim Biophys Acta; 1996 Jul; 1295(2):174-8. PubMed ID: 8695643 [TBL] [Abstract][Full Text] [Related]
39. Incompatibility between complement components C3 and C5 of guinea-pig and man, an indication of their interaction in C5 activation by classical and alternative C5 convertases. Von Zabern I; Nolte R; Vogt W Scand J Immunol; 1979; 9(1):69-74. PubMed ID: 419365 [TBL] [Abstract][Full Text] [Related]
40. Potassium cyanide protects Escherichia coli from complement killing by the inhibition of C3 convertase activity. Bloch EF; Rahbar M; Wright AK; Patterson AM; Souza RF; Hammer CH; Gaither TA; Joiner KA Immunol Invest; 1993 Mar; 22(2):127-49. PubMed ID: 8505069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]